73 related articles for article (PubMed ID: 36834628)
1. Benzimidazole-oxindole hybrids as multi-kinase inhibitors targeting melanoma.
Allam RM; El Kerdawy AM; Gouda AE; Ahmed KA; Abdel-Mohsen HT
Bioorg Chem; 2024 May; 146():107243. PubMed ID: 38457953
[TBL] [Abstract][Full Text] [Related]
2. Modification, biological evaluation and 3D QSAR studies of novel 2-(1,3-diaryl- 4,5-dihydro-1H-pyrazol-5-yl)phenol derivatives as inhibitors of B-Raf kinase.
Yang YS; Zhang F; Tang DJ; Yang YH; Zhu HL
PLoS One; 2014; 9(5):e95702. PubMed ID: 24827980
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing.
Boateng ST; Roy T; Agbo ME; Mahmud MA; Banang-Mbeumi S; Chamcheu RN; Yadav RK; Bramwell M; Pham LK; Dang DD; Jackson KE; Nagalo BM; Hill RA; Efimova T; Fotie J; Chamcheu JC
Chem Biol Drug Des; 2024 Jan; 103(1):e14418. PubMed ID: 38230791
[TBL] [Abstract][Full Text] [Related]
4. Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay.
Li Y; Guo B; Xu Z; Li B; Cai T; Zhang X; Yu Y; Wang H; Shi J; Zhu W
Sci Rep; 2016 Aug; 6():31074. PubMed ID: 27501852
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking approach for the design and synthesis of new pyrazolopyrimidine analogs of roscovitine as potential CDK2 inhibitors endowed with pronounced anticancer activity.
Hamed OA; Abou-Elmagd El-Sayed N; Mahmoud WR; F Elmasry G
Bioorg Chem; 2024 Apr; 147():107413. PubMed ID: 38696844
[TBL] [Abstract][Full Text] [Related]
6. Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors.
Maruca A; Lanzillotta D; Rocca R; Lupia A; Costa G; Catalano R; Moraca F; Gaudio E; Ortuso F; Artese A; Trapasso F; Alcaro S
Molecules; 2020 May; 25(9):. PubMed ID: 32384767
[TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity.
Pinzi L; Foschi F; Christodoulou MS; Passarella D; Rastelli G
ChemistryOpen; 2021 Dec; 10(12):1177-1185. PubMed ID: 34633754
[TBL] [Abstract][Full Text] [Related]
8. Facile synthesis and
Fathy U; Abd El Salam HA; Fayed EA; Elgamal AM; Gouda A
Heliyon; 2021 Oct; 7(10):e08117. PubMed ID: 34693052
[TBL] [Abstract][Full Text] [Related]
9. Quantum-assisted fragment-based automated structure generator (QFASG) for small molecule design: an
Evteev S; Ivanenkov Y; Semenov I; Malkov M; Mazaleva O; Bodunov A; Bezrukov D; Sidorenko D; Terentiev V; Malyshev A; Zagribelnyy B; Korzhenevskaya A; Aliper A; Zhavoronkov A
Front Chem; 2024; 12():1382512. PubMed ID: 38633987
[No Abstract] [Full Text] [Related]
10. Design and Synthesis of New 4-(3,4,5-Trimethoxyphenyl)Thiazole-Pyrimidine Derivatives as Potential Antiproliferative Agents.
El-Damasy AK; Jin H; Sabry MA; Kim HJ; Alanazi MM; Seo SH; Bang EK; Keum G
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374282
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors.
Alanazi AS; Mirgany TO; Alsaif NA; Alsfouk AA; Alanazi MM
Saudi Pharm J; 2023 Jun; 31(6):989-997. PubMed ID: 37234342
[TBL] [Abstract][Full Text] [Related]
12. Modification of imidazothiazole derivatives gives promising activity in B-Raf kinase enzyme inhibition; synthesis, in vitro studies and molecular docking.
Ammar UM; Abdel-Maksoud MS; Mersal KI; Ali EMH; Yoo KH; Choi HS; Lee JK; Cha SY; Oh CH
Bioorg Med Chem Lett; 2020 Oct; 30(20):127478. PubMed ID: 32781217
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors.
Ali IH; Abdel-Mohsen HT; Mounier MM; Abo-Elfadl MT; El Kerdawy AM; Ghannam IAY
Bioorg Chem; 2022 Sep; 126():105883. PubMed ID: 35636123
[TBL] [Abstract][Full Text] [Related]
14. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
[TBL] [Abstract][Full Text] [Related]
15. Developing our knowledge of the quinolone scaffold and its value to anticancer drug design.
Singh Y; Bhatia N; Biharee A; Kulkarni S; Thareja S; Monga V
Expert Opin Drug Discov; 2023; 18(10):1151-1167. PubMed ID: 37592843
[TBL] [Abstract][Full Text] [Related]
16. Discovery of New Quinolone-Based Diarylamides as Potent B-RAF
Kim HJ; Park JW; Seo S; Cho KH; Alanazi MM; Bang EK; Keum G; El-Damasy AK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834628
[TBL] [Abstract][Full Text] [Related]
17. 2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAF
El-Damasy AK; Haque MM; Park JW; Shin SC; Lee JS; EunKyeong Kim E; Keum G
Eur J Med Chem; 2020 Dec; 208():112756. PubMed ID: 32942186
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
